Edition:
United Kingdom

ALK-Abello A/S (ALKb.CO)

ALKb.CO on Copenhagen Stock Exchange

795.00DKK
18 Jan 2018
Change (% chg)

-- (--)
Prev Close
kr.795.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
20,461
52-wk High
kr.1,133.00
52-wk Low
kr.681.00

Select another date:

Thu, Dec 7 2017

BRIEF-ALK-Abello Provides Pricing In New Share Issue

* PRESS RELEASE PRICING AND FURTHER DETAILS ON THE OFFERING OF NEW SHARES IN ALK-ABELLÓ A/S

BRIEF-Alk-Abelló to issue shares in private placement

* ALK-ABELLÓ A/S TO ISSUE UP TO 92,076 AA SHARES AND UP TO 920,760 B SHARES IN A PRIVATE PLACEMENT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Denmark's Alk Abello suspends dividend to support North America investment

Danish pharma company Alk Abello said on Monday it would invest 1 billion Danish crowns (118 million pounds) in its North America business, a move that is expected put a lid on earnings and revenue growth in the near term.

Denmark's Alk Abello suspends dividend to support North America investment

Danish pharma company Alk Abello said on Monday it would invest 1 billion Danish crowns ($159 million) in its North America business, a move that is expected put a lid on earnings and revenue growth in the near term.

UPDATE 1-Denmark's Alk Abello suspends dividend to support North America investment

Dec 4 Danish pharma company Alk Abello said on Monday it would invest 1 billion Danish crowns ($159 million) in its North America business, a move that is expected put a lid on earnings and revenue growth in the near term.

Danish pharma company Alk Abello to invest 1 bln crowns in North America

Dec 4 Danish pharma company Alk Abello said on Monday it would invest about 1 billion Danish crowns ($159.5 million) over the next three years to develop its North America business and said it expected earnings to be subdued during this period.

BRIEF-ALK-Abello To Invest Around DKK 1 Bln In North America​

* ‍WILL INVEST APPROXIMATELY DKK 1 BILLION TO SUCCEED IN NORTH AMERICA​

BRIEF-ALK Reaches Agreement With Health Authorities In France

* ALK SECURES PRICING AND REIMBURSEMENT FOR ACARIZAX® IN FRANCE

BRIEF-Alk-Abello Q3 EBITDA falls to DKK 36 million

* Q3 TOTAL REVENUE DKK ‍667​ MILLION VERSUS DKK 630 MILLION YEAR AGO

BRIEF-Alk appoints new CFO

* ‍HE IS EXPECTED TO TAKE UP HIS NEW ROLE BY 2 JANUARY 2018​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Select another date: